MedTrace Logo

Super-Rehab: a Novel Approach to Treat Atrial Fibrillation

NCT05596175 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-08-12

No results posted yet for this study

Summary

This study proposes to evaluate the effectiveness of a novel lifestyle intervention (Super Rehab), in addition to standard care, for patients with symptomatic atrial fibrillation (AF) requiring rhythm control strategy who are overweight.

As the main driver behind the selection of a rhythm-control strategy for patients with AF, the primary outcome will be an improvement in AF-related symptoms with Super Rehab versus Usual Care only. Secondary outcomes will include the burden of AF, biochemical and cardiac functional and structural changes, and markers of quality-of-life and health resource use.

Conditions

Interventions

BEHAVIORAL

Super Rehab

A 12-month healthcare-delivered lifestyle intervention involving exercise, nutritional support and optimisation of AF-related clinical risk factors.

Sponsors & Collaborators

  • University of Bath

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • Biotronik SE & Co. KG

    collaborator INDUSTRY

  • RUHX (Official NHS Charity for RUH Bath)

    collaborator UNKNOWN

  • Royal United Hospitals Bath NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Ali Khavandi · Royal United Hospital NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-03
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05596175 on ClinicalTrials.gov